Gilead Sciences, Inc.
About Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
2248 articles about Gilead Sciences, Inc.
-
Gilead Sciences, Inc. Appoints John C. Martin as Chairman of Board of Directors; Names John F. Milligan President
5/8/2008
-
Gilead Sciences, Inc. Initiates Letairis(R) (ambrisentan) Phase IV Program
5/2/2008
-
CEO Pay: Who Makes What in Big Biotech?
4/30/2008
-
Gilead Sciences, Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30
4/25/2008
-
Gilead Sciences, Inc. Release: European Commission Approves Viread(R) for Chronic Hepatitis B
4/25/2008
-
Gilead Sciences, Inc. Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B
4/24/2008
-
Robin L. Washington to Join Gilead Sciences, Inc. as Senior Vice President and Chief Financial Officer
4/21/2008
-
Gilead Sciences, Inc. Announces First Quarter 2008 Financial Results
4/17/2008
-
Gilead Sciences, Inc. to Release First Quarter 2008 Financial Results on Wednesday, April 16, 2008
4/10/2008
-
Gilead Sciences, Inc. Release: European CHMP Issues Positive Opinion for Viread(R) for the Treatment of Chronic Hepatitis B
3/20/2008
-
Gilead Sciences, Inc. to Present at Two Upcoming Investor Conferences
3/11/2008
-
Gilead Sciences, Inc. Submits Marketing Authorisation Application for Aztreonam Lysine 75 mg Powder for Nebuliser Solution, a Potential New Treatment for Cystic Fibrosis, to European Medicines Evaluation Agency
3/7/2008
-
Gilead Sciences, Inc. Appoints Dr. John J. Toole as Senior Vice President, Corporate Development
3/7/2008
-
POINT Biomedical Corporation Announces Gilead Sciences, Inc.'s Madeline Miller, D.V.M., Hired as VP, Clinical Operations
3/4/2008
-
Gilead Sciences, Inc. Announces $500 Million Accelerated Share Repurchase
3/3/2008
-
Gilead Sciences, Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Tuesday, February 5
1/31/2008
-
Gilead Sciences, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
1/24/2008
-
Mixed Earnings Forecast for Big Pharma
1/23/2008
-
Gilead Sciences, Inc. Announces Departure of Caroline Dorsa
1/21/2008
-
Gilead Sciences, Inc. to Release Fourth Quarter and Year End 2007 Financial Results on Wednesday, January 23, 2008
1/17/2008